anti-human NAP-2 (CXCL7) monoclonal antibody Anti-Human 500 µg,Reliatech,101-M81
Produced in BALB/c mice using recombinant human NAP-2 as the immunizing antigen. This IgG1/K antibody was purified from a Protein A chromatography column.
Host
Mouse
Reactivity
Human
Application
ELISA
Platform ID
BAB874983239
Reliatech
Contact
Tel: +49 (0) 5331 - 8586987
Fax: +49 (0) 5331- 8586989
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
Nameanti-human NAP-2 (CXCL7) monoclonal antibody Anti-Human 500 µg
Cat. No.101-M81
Accession NumberP02775
HostMouse
IsotypeIgG1, kappa
ReactivityHuman
ApplicationELISA
Appearance/Formlyophilized from PBS
FormulationPBS
ReconstitutionCentrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
StorageThe lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C.
Regulatory StatusFor research use only
Scientific Background
NAP-2 is a CXC chemokine that can signal through the CXCR1 and CXCR2 receptors. It is produced in leukocytes by enzymatic processing of a precursor called platelet basic protein (PBP). NAP-2 chemoattracts and activates neutrophils. Recombinant human NAP-2 protein is a 7-8 kDa protein containing 70 amino acid residues including the four highly conserved cysteine residues present in CXC chemokines, and also including the ELR motif common to CXC chemokines that bind to CXCR1 and CXCR2.
Synonyms
CXCL7, NAP1L4; NAP2; NAP2L; hNAP2; NAP1L4b
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.